Related Experiment Video
Updated: Apr 17, 2026
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
1.3K
Summary
Medical marijuana shows promise for pediatric conditions like seizures, but research is limited. Effective use requires legislative changes, high-quality studies, and standardized marijuana strains for children.
Area of Science:
- Pediatric medicine
- Pharmacology
- Public health policy
Background:
- Medical marijuana is legal for minors in many states, yet not Delaware.
- Anecdotal evidence suggests efficacy for pediatric seizures and adult conditions.
- High-quality pediatric studies are currently lacking.
Purpose of the Study:
- To review the current state of medical marijuana use in children.
- To identify challenges and requirements for effective pediatric application.
- To highlight the need for research and legislative reform.
Main Methods:
- Literature review of existing studies and anecdotal reports.
- Analysis of biochemical, patient-specific, and societal challenges.
- Examination of legislative and regulatory landscapes.
Main Results:
- Limited well-designed studies exist for pediatric medical marijuana use.
- Biochemical, individual, and societal factors present significant challenges.
- Legislative and research hurdles impede widespread, effective use.
Conclusions:
- Effective pediatric medical marijuana use necessitates legislative changes at state and federal levels.
- High-quality research is crucial to establish efficacy and safety in children.
- Standardization of marijuana strains is essential for consistent therapeutic outcomes.
More Related Videos
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
882
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
882
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
367
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
367
01:29Drug Dosing: Infants and Children
915
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
915
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K